Epstein Secrets

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

er Could Apply For FDA's Emergency Authorization Of Vaccine As Soon As This Week. On ABC World News TonightVI (11/15, story 2, 2:15, Llamas, 4.5M), Elwyn Lopez reported Pfizer, "the first drug maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as e

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying